Mustafa Husain
Psychiatry · Durham, NCNPI 1396707154
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (48.8%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 30.9% of the total. Among psychiatry clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 55 payments — averaging $371.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$6K
- Livanova USA, Inc.$6K
- Otsuka America Pharmaceutical, Inc.$5K
- Lundbeck LLC$1K
- Merck$276
- Shionogi Inc$224
- plus $977 from 11 others
Across 62 payments — averaging $2181.74 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Avanir Pharmaceuticals, Inc.$70K
- Alkermes, Inc.$58K
- Abbott$7K
What the payments were for
- Consulting fees$6,21930%
- Speaking & faculty fees$9,99049%
- Travel & lodging$1,8749%
- Food & beverage$2,35111%
- Education$170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 4 | $6,311 |
| Livanova USA, Inc. | 3 | $6,257 |
| Otsuka America Pharmaceutical, Inc. | 16 | $5,028 |
| Lundbeck LLC | 9 | $1,377 |
| Merck | 3 | $276 |
| Shionogi Inc | 2 | $224 |
| Neurocrine Biosciences, Inc. | 5 | $205 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $154 |
| Novartis | 1 | $125 |
| Ferring Pharmaceuticals Inc. | 1 | $119 |
| AstraZeneca | 1 | $110 |
| Baudax Bio Inc. | 1 | $106 |
| Johnson & Johnson | 2 | $51 |
| Axsome Therapeutics, Inc. | 2 | $43 |
| Alkermes, Inc. | 1 | $25 |
| Novo Nordisk | 1 | $22 |
| Bayer | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$20,451 in reported general payments places this provider in the 95th percentile of 1,108 psychiatry providers in North Carolina.
Other psychiatry in Durham
- Mark ReynoldsDurham$3.2M
- Steven SzaboDurham$360K
- Andrew KrystalDurham$234K
- Ranjan SudanDurham$81K
- Caleb WhitenackDurham$68K
- Paolo MannelliDurham$38K
- P DoraiswamyDurham$35K
- David JarrettDurham$28K
- Steven PrakkenDurham$22K
- Damon TweedyDurham$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.